Lipids and Warfarin Requirements

• References

• 1 Nikkila EA, Pelkonen R. Serum lipid-reducing agents and anticoagulant requirements. Lancet 1963; I: 332
• 2 Bentley DP, Backhouse G, Hutchings A, Hadden RL, Spragg B, Routledge PA. Investigation of patients with abnormal response to warfarin. Br J Clin Pharmac 1986; 22: 37-41
• 3 Bjornsson TD, Blaschke T, Meffin P. High performance liquid chromatographic analysis of drugs in biological fluids; (1) Warfarin. J Pharmacol Sci 1977; 66: 142-144
• 4 Nikkila EO, Pelkonen R. Serum tocopherol, cholesterol and triglyceride in coronary heart disease. Circulation 1963; 27: 919-928
• 5 Mann JI, Lewis B, Shepherd J, Winder AF, Fenster S, Rose L, Margan B. Blood lipid concentrations and other cardiovascular risk factors: distribution prevalence and detection in Britain. Br Med J 1988; 296: 1702-1706
• 6 Simpson HC R, Mann JI, Meade TW, Chakrabarti R, Stirling Y, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet 1983; i: 786-790